Antithrombin III deficiency natural history, complications and prognosis

	Antithrombin III deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Antithrombin III deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Antithrombin III deficiency natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Antithrombin III deficiency natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Antithrombin III deficiency natural history, complications and prognosis
CDC on Antithrombin III deficiency natural history, complications and prognosis
Antithrombin III deficiency natural history, complications and prognosis in the news
Blogs on Antithrombin III deficiency natural history, complications and prognosis
Directions to Hospitals Treating Antithrombin III deficiency
Risk calculators and risk factors for Antithrombin III deficiency natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In renal failure, especially nephrotic syndrome, antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis.

Blood clots can cause death, especially if they are in the lungs.

Most patients have a good outcome if they stay on anticoagulant medications.